Patrick Sharma

Cooley advised Vision Government Solutions, a portfolio company of Rubicon Technology Partners and a leader in the appraisal, computer-assisted mass appraisal and property tax industry, on its majority recapitalization with Great Hill Partners.

Cooley advised the underwriters of Duality Biologics (DualityBio), a clinical-stage biotech company focused on the discovery and development of next-generation antibody-drug conjugate therapeutics for patients with cancer and autoimmune diseases, in connection with its HK$1.64 billion global initial public offering (IPO).

Cooley advised the Boston Celtics and the Grousbeck family – the majority stakeholders of Boston Basketball Partners, which owns the American professional basketball team – in connection with their agreement to sell the Celtics to an investor group led by William Chisholm.

Cooley advised Cortica, a leading provider of advanced neurological therapies for children with autism and other developmental differences, on its $80 million financing round, co-led by Morgan Health and Nexus NeuroTech Ventures.

Cooley advised TriSalus Life Sciences, an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, on the closing of its previously announced exchange offer and consent solicitation for special purpose acquisition company warrants. Partner Matt Browne led the Cooley team advising TriSalus.